Study design
This study is a retrospective analysis of all consecutive LTx performed
at Harefield Hospital (London, UK) between June 2012 and December 2018.
Patients who underwent heart-lung transplantation were excluded from
this study. Approval from the Institutional Ethics Committee was
obtained, and all the patients provided their written informed consent
for LTx as well as for donation after circulatory death (DCD). Data were
extracted from the institutional electronic system. Primary endpoints
were posttransplant 30-day and 1-year survival. Secondary endpoints were
early and mid-term postoperative outcomes.